Deutsche Bank’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-392
Closed -$3K 4423
2019
Q4
$3K Buy
392
+32
+9% +$311 ﹤0.01% 4742
2019
Q3
$3K Buy
+360
New +$3.44K ﹤0.01% 4731
2017
Q4
Sell
-116
Closed -$4K 5012
2017
Q3
$4K Buy
+116
New +$5.69K ﹤0.01% 4755
2016
Q3
Sell
-17
Closed -$4K 4961
2016
Q2
$4K Hold
17
﹤0.01% 5028
2016
Q1
$5K Buy
+17
New +$4.79K ﹤0.01% 4951
2015
Q4
Sell
-3
Closed -$1K 5287
2015
Q3
$1K Buy
+3
New +$1.51K ﹤0.01% 5133

Other funds holding DARE

Deutsche Bank's DARE Position: Q1 2020 in Review

Deutsche Bank sold out of Dare Bioscience (DARE) in Q1 2020, closing a stake of 392 shares — an estimated $3K sold.

Deutsche Bank first reported a position in DARE in Q3 2015 and held it in 6 quarters. The position peaked at $5K in Q1 2016. 21 funds tracked by Wall St. Rank hold DARE as of Q1 2020.

  • Deutsche Bank reported no remaining Dare Bioscience position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 392 Dare Bioscience shares in Q1 2020, an estimated $3K.
  • Deutsche Bank first reported a position in Dare Bioscience in Q3 2015 and held it in 6 quarters.
  • Deutsche Bank's Dare Bioscience position peaked at $5K in Q1 2016.
  • 21 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.